Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -51.90% is 182% below its 5-year average of -18.39%, near the low end of its 5-year range (-51.90%–-6.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.50% below its 12-month average of -35.92%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -51.90%.
RETURN ON EQUITY (ROE)
-51.90%
RETURN ON EQUITY (ROE) AVG TTM
-35.92%
RETURN ON EQUITY (ROE) AVG 3Y
-21.38%
RETURN ON EQUITY (ROE) AVG 5Y
-18.39%
RETURN ON EQUITY (ROE) AVG 10Y
-29.08%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.50%
CURRENT VS 3Y AVG
-142.79%
CURRENT VS 5Y AVG
-182.27%
CURRENT VS 10Y AVG
-78.48%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-23.54%
vs the sector median at left
Quanterix Corporation
Market Cap
$163.22M
Return on Equity (ROE)
-51.90%
TTM Avg
-35.92%
3Y Avg
-21.38%
5Y Avg
-18.39%
Market Cap
$163.00M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$168.49M
Return on Equity (ROE)
-47.36%
TTM Avg
-30.00%
3Y Avg
-33.39%
5Y Avg
-32.72%
Market Cap
$165.66M
Return on Equity (ROE)
3.51%
TTM Avg
-6.60%
3Y Avg
-9.04%
5Y Avg
-6.71%
Market Cap
$160.27M
Return on Equity (ROE)
N/A
TTM Avg
101.44%
3Y Avg
117.16%
5Y Avg
-25.56%
Market Cap
$159.44M
Return on Equity (ROE)
-60.19%
TTM Avg
-68.34%
3Y Avg
-61.91%
5Y Avg
-47.91%
Market Cap
$159.22M
Return on Equity (ROE)
-266.86%
TTM Avg
156.76%
3Y Avg
98.17%
5Y Avg
-694.29%
Market Cap
$168.66M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$169.85M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $163.22M | -51.90% | -35.92% | -21.38% | -18.39% |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -215.26% | -150.35% | 8.65% | -35.35% |
| Nkarta, Inc. (NKTX)vs › | $168.49M | -47.36% | -30.00% | -33.39% | -32.72% |
| OptimizeRx Corp. (OPRX)vs › | $165.66M | 3.51% | -6.60% | -9.04% | -6.71% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.27M | N/A | 101.44% | 117.16% | -25.56% |
| PepGen Inc. (PEPG)vs › | $159.44M | -60.19% | -68.34% | -61.91% | -47.91% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -266.86% | 156.76% | 98.17% | -694.29% |
| MediWound Ltd. (MDWD)vs › | $168.66M | -56.61% | -75.88% | -88.15% | -30.55% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | -31.32% | 4.38% | 4.09% | 11.26% |
| Inogen, Inc. (INGN)vs › | $156.90M | -14.07% | -16.23% | -27.66% | -19.01% |
ROE
-51.9%
ROA
-38.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -51.90% |
| 2026-03-31 | -36.93% |
| 2025-12-31 | -36.23% |
| 2025-09-30 | -30.41% |
| 2025-06-30 | -24.11% |
| 2025-03-31 | -15.13% |
| 2024-12-31 | -11.67% |
| 2024-09-30 | -11.60% |
| 2024-06-30 | -11.19% |
| 2024-03-31 | -10.65% |
| 2023-12-31 | -8.94% |
| 2023-09-30 | -10.60% |
| 2023-06-30 | -18.52% |
| 2023-03-31 | -23.69% |
| 2022-12-31 | -27.02% |
| 2022-09-30 | -26.33% |
| 2022-06-30 | -19.42% |
| 2022-03-31 | -15.42% |
| 2021-12-31 | -13.08% |
| 2021-09-30 | -10.42% |
| 2021-06-30 | -6.36% |
| 2021-03-31 | -6.37% |
| 2020-12-31 | -15.30% |
| 2020-09-30 | -15.63% |
| 2020-06-30 | -40.29% |
| 2020-03-31 | -36.12% |
| 2019-12-31 | -31.71% |
| 2019-09-30 | -28.39% |
| 2019-06-30 | -48.79% |
| 2019-03-31 | -97.17% |
| 2018-12-31 | -74.71% |
| 2018-09-30 | -62.04% |
| 2018-06-30 | -53.67% |
| 2018-03-31 | -46.91% |
| 2017-12-31 | -41.02% |
| 2017-09-30 | -406.87% |
| 2017-06-30 | -213.45% |
| 2017-03-31 | -263.50% |
| 2016-12-31 | -196.63% |
